Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action lawsuit due to allegations of deceptive practices related to the promotion and sale of illegitimate versions of the weight loss drug Wegovy®, resulting in a significant drop in its stock price after the termination of its partnership with Novo Nordisk [1][4][5]. Group 1: Company Overview - Hims & Hers Health is a telehealth company that offers prescription and over-the-counter medications, as well as personal care products [3]. Group 2: Legal Allegations - The class action lawsuit claims that during the Class Period, Hims & Hers made false and misleading statements and failed to disclose material facts, including engaging in deceptive promotion of illegitimate versions of Wegovy® [4]. - The lawsuit also alleges that there was a significant risk of Novo Nordisk terminating its collaboration with Hims & Hers due to these deceptive practices [4]. Group 3: Impact of Events - On June 23, 2025, Novo Nordisk announced the termination of its partnership with Hims & Hers, citing concerns over patient safety due to the deceptive promotion of knockoff versions of Wegovy® [5]. - Following the announcement of the partnership termination, Hims & Hers shares fell more than 34% [5].